AMT: ''Power Broker'' to the Global Dental Market -- Continues Shift in Business Strategy

  
    
  
  
    
      American Medical Technologies, Inc. ("AMT") (OTCBB:ADLI) 
      – American Medical Technologies, the leading 
      provider of market-expansion and sales growth services for dealers and 
      distributors in the global dental industry, is successfully continuing 
      its gradual shift in business strategy. AMT is transitioning from an 
      overhead-intense manufacturing model to a lean, revenue-maximizing 
      broker of global dental products. This transition will continue over the 
      next two quarters and is anticipated to substantially increase revenue 
      while simultaneously providing the company significant savings of 
      hundreds of thousands of dollars in overhead costs.
    
    
      By switching to this sales-focused business model, AMT has positioned 
      itself as the critical link between manufacturers of innovative dental 
      products and the global dealers and distributors who sell these highly 
      desired items. Utilizing a global “hub-and-spoke” 
      distribution system, AMT will have the capability to rapidly and 
      efficiently introduce dental products to markets all over the world. 
      Over the past six months AMT has expanded its dental distribution 
      network to include 75 countries through their vast dental distribution 
      federation. AMT is currently in negotiations with several manufacturers 
      and anticipates introducing new products to its global brokering network 
      in the coming months. This new approach has already received 
      enthusiastic support from AMT’s global hub 
      partners and distributors.
    
    
      “Our partnership with AMT is enabling us to 
      introduce and sell products into markets where we were unable to 
      penetrate previously,” says Jos Overmeer, 
      President of ContrastEurope in the Netherlands. “We 
      are very excited that AMT is providing us with the marketing support and 
      global experience needed to help us fulfill our customers’ 
      needs around the world.”
    
    
      “AMT’s new role as 
      a dental ‘power broker’ 
      is bridging the gap between dental manufacturers and global end-users,” 
      says Judd D. Hoffman, President and CEO of AMT. “With 
      our increasing revenue and declining overhead costs, we are in an 
      excellent position to provide on-going value and growth to our 
      shareholders.”
    
    
      About AMT:
    
    
      American Medical Technologies, Inc., headquartered in Corpus Christi, 
      Texas, with satellite offices in Los Angeles, markets and sells unique 
      dental products to the dental community through its established global 
      federation of dealers and distributors. AMT’s 
      premier products, Contrast AM and Contrast PM, a professional tooth 
      whitening product line, delivers excellent whitening results at low 
      costs. AMT was incorporated in Delaware in November 1989 and completed 
      its initial public offering in June 1991. AMT changed its name from 
      American Dental Technologies, Inc. on July 13, 2000.
    
    
      The Company makes forward-looking statements in this press release and 
      in its filings with the Securities and Exchange Commission. The 
      Company's forward-looking statements are subject to risks and 
      uncertainties and include information about its expectations and 
      possible or assumed future results of operations. When the Company uses 
      any of the words "believes," "expects," "anticipates," "estimates," or 
      similar expressions, it is making forward-looking statements. AMT's 
      actual results, performance or achievements could differ materially from 
      the results expressed in, or implied by these forward-looking 
      statements. For more detailed information relating to the risks and 
      uncertainties pertaining to these forward-looking statements, the reader 
      is referred to the "risk-factor" section in AMT's form 10KSB and other 
      related documents filed with the Securities and Exchange Commission.